Nutraceutical International Corp

Find Ratings Reports
NUTR : NASDAQ : Consumer Goods
$25.70 up 1.37 | 5.63%
Today's Range: 24.51 - 25.94
Avg. Daily Volume: 18,600
07/28/16 - 4:00 PM ET

Financial Analysis


NUTRACEUTICAL INTL CORP's gross profit margin for the second quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Sales and net income have grown, and although the growth in revenues has outpaced the average competitor within the industry, the net income growth has not. NUTRACEUTICAL INTL CORP has average liquidity. Currently, the Quick Ratio is 1.13 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 7.21% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY16 Q2 FY15
Net Sales ($mil)59.4955.4
EBITDA ($mil)11.0910.01
EBIT ($mil)7.556.74
Net Income ($mil)4.624.1


Balance Sheet Q2 FY16 Q2 FY15
Cash & Equiv. ($mil)4.165.22
Total Assets ($mil)234.52212.21
Total Debt ($mil)47.538.0
Equity ($mil)166.12154.95


Profitability Q2 FY16 Q2 FY15
Gross Profit Margin55.2553.78
EBITDA Margin18.6318.06
Operating Margin12.6912.16
Sales Turnover0.951.02
Return on Assets7.117.01
Return on Equity10.049.6
Debt Q2 FY16 Q2 FY15
Current Ratio4.344.34
Debt/Capital0.220.2
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q2 FY16 Q2 FY15
Shares outstanding (mil)9.49.6
Div / share0.00.0
EPS0.490.43
Book value / share17.6816.14
Institutional Own % n/a n/a
Avg Daily Volume19979.027091.0

Valuation


BUY. NUTRACEUTICAL INTL CORP's P/E ratio indicates a significant discount compared to an average of 27.33 for the Personal Products industry and a significant discount compared to the S&P 500 average of 25.05. To use another comparison, its price-to-book ratio of 1.36 indicates a discount versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 20.17. The price-to-sales ratio is well below both the S&P 500 average and the industry average, indicating a discount. Upon assessment of these and other key valuation criteria, NUTRACEUTICAL INTL CORP proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
NUTR 13.66 Peers 27.33   NUTR 7.25 Peers 16.16

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

NUTR is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

NUTR is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
NUTR NA Peers 21.40   NUTR NA Peers 1.94

Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential.

Ratio not available.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
NUTR 1.36 Peers 20.17   NUTR 14.28 Peers -19.06

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

NUTR is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

NUTR is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
NUTR 1.01 Peers 2.25   NUTR 3.21 Peers 1.24

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

NUTR is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

NUTR has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades